Zeder Investments Ltd. Overview
Zeder Investments is a Stellenbosch-based, JSE-listed investment holding company in the PSG Group stable. It was created in 2006 to take long-term strategic stakes across the South African agribusiness value chain. At its peak (FY2018–FY2020) the portfolio was valued at R11–14bn and included Pioneer Foods, Kaap Agri, Capespan, The Logistics Group, Quantum Foods, Agrivision Africa and Zaad. Since 2020 Zeder has run a deliberate value-realisation programme. It sold or unbundled almost every asset and returned more than R8.6bn to shareholders through special dividends and unbundlings. At 28 February 2026 its sum-of-the-parts (SOTP) value was R2.316bn, or R1.50 per share. This consisted almost entirely of Zaad, a specialist seed and agrochemical group, and a 48.6% look-through stake in Türkiye's May Seed. The sale of Zaad (excluding May Seed and other excluded assets) to a consortium of WIPHOLD, the PIC, Phatisa and the IDC for up to R1.39bn is awaiting regional competition approvals. Zeder is therefore best characterised as a late-stage liquidation and distribution vehicle with one residual foreign asset.
Company's own description
In its FY2026 results Zeder describes itself as an investor in the broad agribusiness and related industries, with a total SOTP value of R2.3bn at 28 February 2026. Its stated objective is to maximise long-term wealth for shareholders, and its key performance benchmark is SOTP value per share (Zeder FY2026 reviewed results, 23 April 2026). Earlier disclosures (FY2024) describe a corporate role of assisting with portfolio and investee strategies and overseeing capital allocation to ensure sustainable investment returns.
Business model and accounting basis
Zeder meets the definition of an Investment Entity under IFRS 10. It does not consolidate its portfolio companies. Instead it measures them at fair value through profit or loss under IFRS 9 and IFRS 13, and all investments are Level 3 (unlisted) as at FY2026. As a result:
"Revenue": at the reported level consists of investment income (interest on cash and shareholder loans, plus dividends from portfolio companies). It was R144m in FY2026 (continued R15m + discontinued R129m) and R536m in FY2025 (re-presented), the latter inflated by R484m of special dividends from Pome Investments.
Value creation (or destruction): shows up mainly as fair value gains or losses on investments: a net R479m loss in FY2026 and a net R652m loss in FY2025.
Costs: are head-office marketing, administration and other expenses (R38m in FY2026) plus transaction costs (R39m in FY2026, including R28m paid to PSG Capital for corporate finance work).
Cash returns: to shareholders come through special dividends, funded by realisations, rather than ordinary dividends.
The revenue model is therefore neither product, service, subscription nor licensing. It is capital appreciation plus investment income from strategic, mostly controlling stakes in private agribusinesses. The portfolio companies themselves (chiefly Zaad) earn product revenue from selling proprietary and distributed seed varieties and agrochemicals.
Portfolio composition at 28 February 2026 (FY2026 SOTP)
| Component | Interest (%) | Value (ZAR Mn) | Share of investments (%) | Valuation method |
|---|---|---|---|---|
| Zaad (excluding Zaad International / May Seed) – held for sale | 97.2 | 1,094 | 61 | Agreed transaction value |
| Zaad International (May Seed) – continued investment | 97.2 (look-through 48.6% of May Seed) | 694 | 39 | EV/EBITDA multiple |
| Pome Investments – held for sale | 87.1 | 8 | 0.4 | Net asset value |
| Total investments and assets held for sale | — | 1,796 | 100 | — |
| Cash and cash equivalents | — | 231 | — | — |
| Other net assets and liabilities (mainly R361m Zaad shareholder loan claim) | — | 289 | — | — |
| SOTP value | — | 2,316 | — | — |
| SOTP value per share (R) | — | 1.50 | — | — |
Source: Zeder FY2026 reviewed results, Annexure A.
Value-chain position, customers and end-markets
Historical position (to 2020): Zeder spanned the agri value chain from inputs (Zaad seed and chemicals), through primary production and fruit marketing (Capespan), logistics and terminals (The Logistics Group), agri-retail and fuel (Kaap Agri), to FMCG (Pioneer Foods, Quantum Foods).
Current position: almost entirely agri-inputs. Zaad owns, develops, imports and distributes agricultural seed (field crops, oilseeds, forage, vegetables) and agrochemicals and fertilisers. Its customers are commercial and emerging farmers, distributors, co-operatives and dealers in South Africa, East Africa, Europe and the Middle East. May Seed serves Turkish and regional seed markets.
End-markets: grain and oilseed production (maize, soybean, sunflower, canola), pasture and forage, vegetable production, and crop protection. Demand is driven by planted area, weather, commodity prices, farmer financial health and currency.
Independent characterisation
Zeder should no longer be analysed as a going-concern agribusiness compounder. It is a realisation vehicle. Over FY2021–FY2026 it converted a diversified portfolio into cash and returned the proceeds, and the remaining value depends on three things:
-
completing the Zaad sale (R1.029bn equity value plus R361m loan claim to Zeder);
-
how much of the proceeds the board distributes versus retains against warranty exposure (capped at 30% of consideration); and
-
the eventual monetisation of the 48.6% look-through May Seed stake (R694m, valued at 5.7x EV/EBITDA after a 35% company-specific and 20% marketability discount).
The board has not articulated any new-investment strategy.
Strategy
Stated strategy (themes from FY2026 results and earlier disclosures)
-
Maximise long-term wealth for shareholders, measured by SOTP value per share. This has been repeated in every results announcement since FY2022.
-
Realise assets at respectable value and distribute proceeds. The board describes each disposal as consistent with the strategic review that began after unsolicited approaches in 2021.
-
Distribute a significant portion of the Zaad proceeds after costs and directly related obligations. The board may hold back an appropriate portion because Zeder's maximum liability for proven, uninsured warranty breaches is 30% of the disposal consideration (except in cases of fraud).
-
Evaluate options for Zaad International (May Seed) to further maximise shareholder wealth. No decision has been announced.
-
Conservative dividend policy. Dividends are paid only if the group has enough cash to fund operations and investee growth plans. Special dividends are paid as realisations allow.
Strategic initiatives in the last 24 months (Oct 2024 – Oct 2026)
| Initiative | Timing | Status / target |
|---|---|---|
| Disposal of Pome Investments operating assets (three farms, Novo packhouse) | Nov–Dec 2024 | Completed; R713m gross, R621m attributable; R477m distributed |
| Zaad portfolio clean-up: sale of Zimbabwe, Mozambique, Zambia operations to ETG Inputs | Announced 26 Mar 2025 | R135m. Not yet complete at Feb 2026 (still an Excluded Asset in process) |
| Disposal of Angolan chemical operations (Angata) | Implemented Feb 2026 | Completed; value not disclosed |
| Category 1 disposal of Zaad (excl. Excluded Assets) | Signed 31 Jan 2026 | Up to R1.39bn to Zeder; long-stop 30 Nov 2026 |
| Restructure May Seed into Zaad International (Mauritius) | Before Zaad completion | Pending; a condition precedent |
| EA Seed Transaction (Zaad International B.V. to acquire 60% of EA Seed Group companies) | Condition precedent to Zaad sale | Sale and purchase agreement concluded; internal conditions outstanding (May 2026) |
| Leadership transition to acting CEO/FD | Mar 2026 | Completed |
Sustainability, cost programmes and medium-term targets
-
No formal cost-reduction programme with quantified targets has been disclosed.
-
No ESG targets have been disclosed.
-
Management medium-term financial targets / guidance: none provided. Zeder gives no earnings or NAV guidance. Its outlook statements are qualitative: continued uncertainty and volatility in its markets, a stable balance sheet, and sufficient cash resources.
Products & Services
Zeder itself has no products. The catalogue below covers the businesses inside the remaining portfolio, as disclosed in Zeder filings. Launch years, product specifications and pricing models are not publicly disclosed in Zeder's filings unless stated.
Zaad Holdings (97.19%) — sale pending to the WIPHOLD/PIC/Phatisa/IDC consortium
| Business | Description and offering (as disclosed) | Target customer | Recent performance notes |
|---|---|---|---|
| Agricol | Develops and markets field-crop and oilseed seed. Disclosed crops include canola, soybean, sunflower and maize. A key player in the soya and canola markets | Commercial grain and oilseed farmers in South Africa | Record soybean sales in the 2025/26 early summer season; maize sales grew; the 2024/25 sunflower season was below average. In H1 Dec2022 it reported its best six months in history, helped by oilseed prices after the Russia–Ukraine conflict |
| Klein Karoo Seed Marketing (KKS / "K2") | Long-established seed producer and marketer. Zaad describes Agricol and KKS together as having more than 50 years of heritage. Its African subsidiaries (Zimbabwe, Mozambique, Zambia) are being sold to ETG Inputs as the "K2 Africa Business" | Farmers and distributors in Southern Africa | African entities classified as Excluded Assets and being sold |
| K2 Seed Growers | Seed production linked to the vegetable hybrid transition | Seed industry / internal supply | Lower earnings due to a slower F1 hybrid transition (FY2026) |
| Hygrotech | Vegetable seed production, processing and distribution; seed breeding; soft agrochemicals and fertilisers (merged with Zaad in 2018) | Vegetable growers | "Continued its growth trajectory" after restructuring (FY2026) |
| FarmAg | Hard agrochemicals and fertilisers; trades in South Africa and exports | Farmers, distributors, export customers | H1 Dec2025 earnings rose on product-mix-driven margins despite slightly lower revenue; stricter export credit control; reduced fertiliser sales to Angata after the disinvestment. Raw material price deflation hurt H1 Dec2023 |
| Bakker Brothers (Gebroeders Bakker, Netherlands) | Vegetable seed company moving towards a fully fledged intellectual-property, R&D-led F1 hybrid vegetable seed model | International vegetable seed distributors and growers | Transition taking longer than expected; underperformance noted in FY2026; IP relating to the sold African operations transferred to ETG |
| EA Seed (East African Seed; EA Seed Group Ltd, Mauritius; Syova Seeds Zambia) | Seed company established in 1972 and headquartered in Nairobi, with operations in Kenya, Uganda, Rwanda, Tanzania and Zambia, selling through dealers and stockists | East and Central African farmers | Good H1 Dec2025: growth in Uganda and Tanzania, recovery in Zambia, pressure in Kenya. A related "EA Seed Transaction" (Zaad International B.V. acquiring 60% of the EA Seed Group companies) is a condition precedent of the Zaad sale |
| Angata Limitada (Angola) | Distributor of chemicals and fertilisers | Angolan market | Disposal implemented February 2026 (Excluded Asset) |
| ZARP, Pristine Marketing and other Zimbabwe/Mozambique/Zambia entities | Seed and agri-input operations | Southern African farmers | Being sold to ETG Inputs (R135m) |
Zaad International (Mauritius) / May Seed (look-through 48.6%) — to be retained by Zeder
| Item | Detail |
|---|---|
| Legal entity | May Agro Tohumculuk Sanayi ve Ticaret A.S., Bursa, Türkiye |
| Business | Specialist agricultural seed |
| 100% revenue (LTM Nov 2025, inflation-adjusted, ZAR) | R955m |
| 100% normalised EBITDA | R371m |
| 100% normalised headline earnings | R168m |
| Net debt and cash | R(262)m |
| Valuation | 5.7x EV/EBITDA; 35% company-specific discount; 20% marketability discount; TRY:ZAR 1:0.362 |
| Commercial note | A large part of sales is in hard currency, mitigating lira depreciation (FY2024 commentary) |
Source: Zeder FY2026 results, Annexure A note A.
Pome Investments (87.1%)
Pome Investments formerly owned Capespan Agri, which had three primary pome (apple and pear) farming production units in the Western Cape and the Novo fruit packhouse in Paarl. All operating assets were sold in November–December 2024 for R713m. The company now holds mainly cash, valued at net asset value (R8m at FY2026 after dividends). It paid a further R10m dividend to Zeder on 17 April 2026.
Financial Narrative
Basis of preparation. FY2022 figures come from the FY2022 results announcement (13 April 2022) and secondary data where noted. FY2023–FY2024 figures come from Zeder's FY2024 reviewed results. FY2025–FY2026 figures come from Zeder's FY2026 reviewed results, with FY2025 re-presented for discontinued operations; the totals shown combine continued and discontinued operations. Concepts such as gross profit, operating income and EBITDA do not exist in an Investment Entity's income statement and are shown as n/m.
Income statement
FY2022 net profit is per ShareData/TraderFox and is consistent with EPS of 52.1c × about 1.54bn shares.
Margins are not meaningful because "revenue" includes fair value movements and is negative in three of four years. Revenue CAGR is likewise n/m.
Commentary.
FY2022: was the last profitable large year. Fair value gains on TLG, Capespan and Kaap Agri lifted NAVPS 7.6% to 466.1c. FY2021 had attributable EPS of 152.8c, inflated by the Pioneer Foods realisation and deconsolidation effects.
FY2023: shows the accounting footprint of the break-up. A R193m fair value loss on KAL Group shares arose because the KAL share price fell between 28 February 2022 and the 4 April 2022 unbundling date. There was also a capital gains tax charge on distributing KAL shares to a disqualified shareholder (R18m discontinued-operations tax).
FY2024: was roughly breakeven (R12m). A R48m gain on Pome Investments, after a strong 2023 pome season, offset a R42m Zaad write-down caused by FarmAg's chemical margin collapse.
FY2025: losses (R154m) were driven by a R466m reduction in Pome Investments' value. That reduction mirrored the R484m of special dividends Pome paid up to Zeder, so it is a value transfer rather than economic destruction. The genuine economic loss was the R223m write-down of Zaad (excluding May Seed), caused by lower valuations of Zaad's Turkish associate and African operations.
FY2026: losses (R421m) mainly reflect marking Zaad (excluding May Seed) to the R1.029bn agreed sale price (R368m loss) and R39m of transaction costs.
Balance sheet
Notes:
-
FY2022 investments are the stated portfolio value of R6.43bn.
-
FY2022 cash is the opening cash in the FY2023 cash-flow statement.
-
Zero borrowings in FY2023–FY2026 are confirmed by the statements of financial position, which show only employee benefits and trade payables as liabilities. All debt was settled in March 2020 from Pioneer Foods proceeds.
-
Goodwill is zero in each year shown because net tangible asset value per share equals NAV per share.
-
FY2026 working capital (derived) = loans R361m + receivables R1m + tax R3m + assets held for sale R1,102m + cash R231m − liabilities R73m.
Cash flow
Notes:
-
FY2022 dividends paid are the 20c special dividend (R308m) paid in May 2021 (Business Day, 14 Apr 2021).
-
FY2025 operating cash flow includes R484m of dividends received from Pome Investments.
Ratios
Notes:
-
The current ratio is derived from FY2026 balances. Morningstar shows 23.54x.
-
NAV total return = (closing NAVPS + special dividends paid + unbundled value per share) ÷ opening NAVPS − 1. FY2022 uses opening NAVPS of 433.2c. FY2023 includes the KAL unbundling at its date-of-distribution fair value (about 91c per share, being R1,403m ÷ about 1,543m shares). The company also quotes the unbundling at R1.03 per share using the pre-unbundling valuation.
-
ROIC, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are n/m: there is no debt, no EBITDA and no operating working capital cycle.
Analytical takeaways.
-
The NAVPS collapse from 466.1c (FY2022) to 150.4c (FY2026) is mostly distributions, not losses. Over FY2023–FY2026, Zeder paid 178.5c in special dividends and unbundled about 91c of KAL value, a total of about 270c per share. That compares with a cumulative NAVPS decline of 316c, so about 46c per share (about 15% of the decline) is genuine value erosion. Most of that erosion came from Zaad.
-
The balance sheet is debt-free and liquid. FY2026 liabilities were R73m against R2.39bn of assets.
-
FY2026 shows real value destruction (-15.1% NAV total return). The Zaad transaction price came in well below the R1.462bn carrying value of a year earlier.
-
Head-office cost intensity is rising as the asset base shrinks. Marketing and administration costs were R38m in FY2026 versus R21m in FY2025 (continued operations), about 1.6% of SOTP before transaction costs.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Assets & Liabilities
| Segment / investment (ZAR Mn) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Zaad including May Seed (as originally reported) | 2,384 | 2,342 | 2,156 | 1,788 |
Zaad excluding May Seed (restated) | — | — | 1,462 | 1,094 |
Zaad International (May Seed) (restated) | — | — | 694 | 694 |
Capespan including Pome Investments | 1,046 | — | — | — |
Pome Investments | — | 585 | 119 | 8 |
Other investments | 15 | 4 | — | — |
Total investments and assets held for sale | 3,445 | 2,931 | 2,275 | 1,796 |
Segment headline earnings (ZAR Mn)
| Segment headline earnings (ZAR Mn) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Zaad (incl. May Seed, as reported) | 21 | -34 | — | — |
Zaad excluding May Seed (restated) | — | — | -196 | -389 |
Zaad International (May Seed) (restated) | — | — | 37 | 0 |
Capespan / Capespan excl. Pome | -7 | 6 | — | — |
Pome Investments | — | 49 | 19 | 0 |
Other | 22 | 1 | — | — |
The Logistics Group (discontinued) | -12 | — | — | — |
KAL Group (discontinued) | -193 | — | — | — |
Agrivision Africa (discontinued) | 13 | — | — | — |
Unallocated / head office | 2 | 5 | 0 | -23 |
Total before tax | -154 | 27 | -140 | -412 |
Segment Overview
| Segment | FY2026 value (ZAR Mn) | % of investments | YoY change (ZAR Mn) | YoY change (%) |
|---|---|---|---|---|
Zaad excl. May Seed | 1,094 | 61 | -368 | -25.2 |
Zaad International (May Seed) | 694 | 39 | 0 | 0.0 |
Pome Investments | 8 | 0.4 | -111 | -93.3 |
Results by Segment
| Zaad metric (ZAR Mn) | H1 Dec2022 | H1 Dec2023 | FY Jun2024 | FY Jun2025 | H1 Dec2025 |
|---|---|---|---|---|---|
Recurring headline earnings | 124 | 65 | 160 | 129 | 55 |
Zaad Valuation Inputs, LTM Dec 2023 Details
| Zaad valuation inputs, LTM Dec 2023 (ZAR Mn) | Value |
|---|---|
Group recurring EBITDA (incl. proportionate associates) | 568 |
Net debt and cash (incl. shareholder loan) | 1,037 |
Recurring headline earnings | 180 |
Seed subsidiaries EBITDA | 211 |
Chemical subsidiaries EBITDA | 113 |
Seed associates EBITDA (proportionate) | 243 |
EV/EBITDA multiples applied | Seed 7–8x; Chemical 8–9x; Seed associates 5–8x |
Income Statement
| Metric (ZAR Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Investment income (interest + dividends), total | — | 40 | 54 | 536 | 144 |
Net fair value gain/(loss) on investments, total | — | -168 | 6 | -652 | -479 |
Other operating income | — | 27 | 1 | 0 | 0 |
Total net income ("revenue" proxy) | — | -101 | 61 | -116 | -335 |
Marketing, administration, transaction and other costs | — | -53 | -34 | -24 | -77 |
Profit/(loss) before tax, total | — | -154 | 27 | -140 | -412 |
Taxation | — | -33 | -15 | -14 | -9 |
Net profit/(loss) attributable | 801 | -187 | 12 | -154 | -421 |
Profit/(loss) from continued operations | — | 23 | 12 | 31 | -27 |
Profit/(loss) from discontinued operations | — | -210 | 0 | -185 | -394 |
Per-share metric (cents)
| Per-share metric (cents) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Attributable EPS – basic | 52.1 | -12.1 | 0.8 | -10.0 | -27.3 |
Attributable EPS – diluted | — | -13.4 | 0.3 | -10.0 | -27.3 |
Headline EPS – basic | 52.1 | -12.1 | 0.8 | -10.0 | -27.3 |
Special dividends paid in year (gross) | 20.0 | 102.5 | 15.0 | 61.0 | 0.0 |
Net asset value per share | 466.1 | 260.3 | 248.3 | 177.1 | 150.4 |
SOTP value per share | 466 | 260 | 248 | 177 | 150 |
Margin / growth metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
Balance Sheet
| Metric (ZAR Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total investments incl. assets held for sale | 6,431 | 3,445 | 2,931 | 2,275 | 1,796 |
Loans and advances (mainly to Zaad) | — | 2 | 217 | 343 | 361 |
Cash and cash equivalents | 508 | 598 | 694 | 160 | 231 |
Total assets | — | 4,101 | 3,877 | 2,782 | 2,389 |
Total borrowings (short + long) | — | 0 | 0 | 0 | 0 |
Net cash (cash less borrowings) | — | 598 | 694 | 160 | 231 |
Total liabilities | — | 92 | 53 | 55 | 73 |
Total equity (= SOTP value) | 7,168 | 4,009 | 3,824 | 2,727 | 2,316 |
Goodwill and intangibles | — | 0 | 0 | 0 | 0 |
Working capital, derived (current assets less current liabilities, excl. long-term investments) | — | — | — | — | 1,625 |
Cash Flow
| Metric (ZAR Mn) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash flow from operating activities | — | -25 | 17 | 467 | 71 |
Cash flow from investing activities | — | 1,706 | 314 | -62 | 0 |
Disposal and earn-out proceeds received | — | 1,705 | 522 | 34 | 0 |
Capex | — | 0 | 0 | 0 | 0 |
Free cash flow (operating cash flow less capex) | — | -25 | 17 | 467 | 71 |
Dividends paid to shareholders | 308 | 1,575 | 231 | 939 | 0 |
Share buybacks and treasury share purchases | — | 16 | 4 | 0 | 0 |
Net change in cash | — | 90 | 96 | -534 | 71 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%) (net profit / average equity) | — | -3.3 | 0.3 | -4.7 | -16.7 |
ROA (%) (net profit / average total assets) | — | — | 0.3 | -4.6 | -16.3 |
Current ratio (x) (derived) | — | — | — | — | 23.2 |
Debt/equity (x) | — | 0 | 0 | 0 | 0 |
NAV total return per share (%) (derived) | 12.2 | -2.6 | 1.2 | -4.1 | -15.1 |
Cash as % of SOTP | 7.1 | 14.9 | 18.1 | 5.9 | 10.0 |
Revenue by Region
| Investment value by geography (ZAR Mn) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
South Africa-incorporated Zaad (operating in Southern Africa and Europe) excl. May Seed | — | 1,462 | 1,094 |
Türkiye exposure via Zaad International (Mauritius) / May Seed | — | 694 | 694 |
South Africa – Pome Investments | 585 | 119 | 8 |
Zaad combined (not split by geography) | 2,342 | — | — |
Share Price History
| Date | Price (R) | Source / note |
|---|---|---|
28 Feb 2019 | 4.23 | Zeder FY2022/FY2023 results |
14 Apr 2021 | 3.08 | Business Day (market value R4.7bn) |
28 Feb 2023 | 1.72 | Zeder FY2023 results |
Sep 2023 | about 1.69 | Implied by about R2.6bn market value (News24, 19 Sep 2023) |
31 Aug 2024 | about 1.93 | Implied by R2,972m market cap (ShareData) |
31 Aug 2025 | about 1.27 | Implied by R1,956m market cap (ShareData) |
2 Feb 2026 | 1.15 | SENS 3 Feb 2026 |
23 Apr 2026 | 1.31 | Business Report |
5 Jun 2026 | 1.19 | Investing.com |
3 Sep 2026 | 1.03 | SA Shares (market cap R1.59bn) |
22 Sep 2026 | 1.04 | Morningstar; 52-week range R0.91–R1.45 |
Share Price & Returns
| Horizon (to 22 Sep 2026) | Price change (%) | Distributions received over period (cents) | Approximate total return, undiscounted, no reinvestment (%) |
|---|---|---|---|
1 year (from about R1.27, Aug 2025) | -18 | 7 | -13 |
3 years (from about R1.69, Sep 2023) | -38 | 78 | 8 |
5 years (from R3.08, Apr 2021) | -66 | 296.5 | 30 |
Valuation Multiples
| Multiple | Zeder | Note |
|---|---|---|
P/E | n/m | Loss-making (FY2026 EPS -27.3c) |
EV/EBITDA | n/m | No consolidated EBITDA |
EV/Sales | n/m | No revenue in the conventional sense |
P/B (price / NAVPS) | 0.69 | R1.04 / R1.504 (FY2026); Morningstar also shows 0.69 |
Price / pro forma SOTP (after 7c dividend and R10m Pome receipt) | about 0.73 | Pro forma SOTP about R2.218bn (about R1.44 per share) |
Implied enterprise value | about R1.37bn | Market cap about R1.60bn less Feb 2026 cash R231m (indicative) |
Dividend metric
| Dividend metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|
Special dividends paid (gross, cents per share) | 230.0 | 20.0 | 102.5 | 15.0 | 61.0 | 0.0 |
Special dividends paid (ZAR Mn) | 3,900 | 308 | 1,575 | 231 | 939 | 0 |
Analyst Conclusions
Management guidance
Qualitative only: Management expects uncertainty and volatility to persist in its markets, says Zeder is well positioned with a stable balance sheet and cash, intends to distribute a significant portion of the Zaad proceeds while possibly holding some back, and is evaluating options for Zaad International (May Seed). (FY2025 and FY2026 results.)
No NAV, earnings or dividend targets: have been issued.
Consensus growth expectations: none (no analyst coverage).
Illustrative pro forma value bridge (analyst construction from disclosed figures; not company guidance)
| Item (ZAR Mn) | Amount | Basis |
|---|---|---|
| FY2026 SOTP | 2,316 | FY2026 results |
| Less 7c special dividend paid Jun 2026 | -108 | 7c × 1,540m shares |
| Plus Pome dividend received Apr 2026 | 10 | FY2026 note 9 |
| Pro forma SOTP | 2,218 | about R1.44 per share |
| of which: Zaad equity (incl. R65m excluded-asset proceeds) | 1,094 | FY2026 SOTP |
| of which: Zaad loan claim | 361 | FY2026 note 8 |
| of which: May Seed (via Zaad International Mauritius) | 694 | FY2026 SOTP |
| of which: cash, Pome residual and other net liabilities | 69 | Balancing figure |
Implication. Suppose Zaad completes on terms and the board distributes about R1.0bn (about 65c per share). The residual pro forma SOTP would then be about 79c per share, of which about 45c is May Seed. At R1.04 the market implicitly prices the post-distribution residual at about 39c. That implies a discount of roughly 50% on the residual, reflecting the hold-back, warranty exposure, timing risk and the Türkiye discount. The distribution size is an assumption for illustration only.
Bull case (three arguments)
-
Cash catalyst well above the share price. Zaad completion delivers up to R1.39bn to Zeder (about 90c per share gross), backed by bank guarantees. That is a large share of a R1.04 share price, before counting May Seed or existing cash.
-
May Seed is undervalued on Zeder's books. At 5.7x EBITDA after 35% and 20% discounts, the R694m carrying value is conservative relative to R371m of EBITDA at 100% (R180m look-through at 48.6%). Any sale or listing route could crystallise more.
-
Track record. Zeder has consistently turned assets into cash and paid it out (more than R8.6bn over six years). The 3- and 5-year total returns (about +8% and +30%) are positive despite falling share prices, and the remaining structure is simple.
Bear case (three arguments)
-
Timing and leakage risk. Regional approvals already forced a four-month long-stop extension. Locked-box leakage, transaction costs, the deferred vendor loan and a prudential hold-back against the 30% warranty cap could shrink and delay the cash actually paid out.
-
Value-erosion pattern. Zaad's carrying value fell 35% from Feb 2024 to the agreed deal value, and FY2026 NAV total return was -15.1%. The May Seed mark could also prove optimistic in a sale, especially with the lira weak.
-
Stranded-shell economics. After the Zaad sale, a sub-R1bn vehicle holding one Turkish minority stake carries head-office costs (R38m in FY2026) and PSG-related fees. That favours a persistent discount and possible further cost leakage unless the board sets a clear wind-up or exit timetable.
Key catalysts and monitorables (next 12 months)
-
Interim results (about 21–22 Oct 2026): Zaad transaction status, H1 Dec2026 trading, May Seed valuation, cash balance.
-
COMESA, EAC and Tanzanian FCC approvals, plus SARB and lender consents, ahead of the 30 Nov 2026 long-stop.
-
Effective date of the Zaad sale and the size of the first distribution (and SARB timing for it).
-
Board decision on Zaad International (May Seed): sale, distribution in specie, or hold.
-
Collection of the R61m vendor loan (due within 12 months of the effective date) and the R65m of Excluded-Asset proceeds (including the ETG Inputs deal).
-
Permanent CEO appointment, or a formal wind-up/delisting strategy.
-
FY2027 results (about April 2027) and any release of the hold-back.
Concluding analyst verdict
Zeder Investments has largely finished the job it set itself in 2020. It has dismantled a once-diversified agribusiness portfolio and returned the proceeds. Since the Pioneer Foods exit it has sold or unbundled Quantum Foods, The Logistics Group, Kaap Agri, Agrivision Africa, Capespan and the pome farming assets, and returned more than R8.6bn to shareholders. The remaining equity story rests on two assets and one decision. The two assets are the pending R1.39bn Zaad sale and a 48.6% look-through stake in Türkiye's May Seed. The decision is how much of the Zaad cash the board pays out versus holds back.
The evidence supports a cautiously constructive view, with clear qualifications. The deal is financially de-risked: bank guarantees, shareholder approval, unconditional domestic competition clearance and W&I insurance are in place. The share price (R1.04) sits about 27% below the pro forma SOTP (about R1.44). The balance sheet is debt-free, and the market is pricing the post-distribution residual very harshly. Against that, the realised price for Zaad confirmed that earlier Level-3 marks were too high. May Seed carries real currency and geopolitical risk. Regional regulators have already delayed completion. The 30% warranty cap gives the board a reason to retain a meaningful portion of proceeds for some time.
For long-horizon, special-situation investors, Zeder looks like an event-driven liquidation trade. The main payoff depends on completion before 30 November 2026 and on the size of the first special dividend. Upside optionality comes from monetising May Seed. Investors who need governance clarity, liquidity or recurring income will find little here until the board sets out an explicit endgame for the residual vehicle. The October 2026 interim results and the regional approvals are the decisive near-term signals.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Classification | Background (as publicly disclosed) |
|---|---|---|---|
CA (Chris) Otto | Chairman | Independent non-executive | Co-founder of PSG Group (Business Day, 2022). Member of the Independent Board for the Zaad transaction |
A (Dries) Mellet | Financial Director and acting CEO (from 1 Mar 2026) | Executive | CA(SA). Supervised preparation of the FY2026 results |
JH (Johann) le Roux | Non-executive director; member of executive committee | Non-executive | CA(SA). Acting CEO from 1 Oct 2020, then CEO and FD until 28 Feb 2026; led the 2021–2026 realisation programme |
PJ (Piet) Mouton | Non-executive director | Non-independent (PSG) | CEO of PSG Group; son of PSG founder Jannie Mouton |
WL Greeff | Non-executive director | Non-independent (PSG-affiliated) | Detailed biography not disclosed in the sources reviewed |
S Cassiem | Non-executive director | Independent | Member of the Independent Board for the Zaad transaction |
NS Mjoli-Mncube | Non-executive director | Independent | Member of the Independent Board for the Zaad transaction |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Oct 2020 | Johann le Roux appointed acting CEO | Followed the Pioneer Foods exit and the start of the value-unlock phase |
Apr 2021 | Le Roux appointment as CEO confirmed | FY2021 results announcement |
28 Feb 2026 | Le Roux stepped down as CEO and FD; stays as non-executive director | After signing the Zaad sale agreement; the company is shrinking towards a shell |
1 Mar 2026 | Dries Mellet appointed FD and acting CEO | Interim leadership through Zaad completion and distribution |
Major Shareholders
| Holder | Stake | Basis |
|---|---|---|
PSG Group (Pty) Ltd (unlisted; Mouton family, PSG management and associates) | about 48.6% | PSG stated it would retain 48.6% of Zeder (Moonstone, Mar 2022). Consistent with related-party dividends: R456m of R939m in FY2025 (48.6%), R112m of R231m in FY2024 (48.5%), R767m of R1,575m in FY2023 (48.7%) |
Competitive Landscape
Key Competitors
| Peer | Relevance to Zeder | Positioning note |
|---|---|---|
Remgro | Stellenbosch-based diversified holding company with large unlisted food and agri exposure | Discount to intrinsic NAV narrowed from the 40s by Sep 2026 (Daily Maverick, 27 Sep 2026) |
Sabvest Capital | Mostly unlisted portfolio; partnership model | Discount about 12% (Sep 2026); seen as a best-practice holding company |
Brait | Consumer and industrial holdings | Deep discount; realising assets (Premier share placement) |
Hosken Consolidated Investments (HCI) | Diversified holding company | Historically among the widest discounts |
Reinet | Listed holding company | Discount around 30% (PSG research, Nov 2025) |
Brimstone | Diversified holding company | Discount 30–50% band (Financial Mail) |
Astoria Investments | Small-cap holding company | — |
African Rainbow Capital | Diversified unlisted holding company | — |
KAL Group (Kaap Agri) | Former Zeder investee; listed agri-retail | Direct agri exposure alternative |
Agrarius | Agri value-chain investor (bought Capespan) | Private-market competitor for agri assets |
Peer Comparison FY2026
| Metric | Zeder (ZED) | Sabvest | Remgro | Brait |
|---|---|---|---|---|
Portfolio type | Two unlisted agri-input assets; realisation phase | Mostly unlisted industrial/consumer | Mixed listed/unlisted | Unlisted consumer and industrial |
Discount to NAV/SOTP | about 31% to Feb 2026 SOTP (R1.04 vs R1.50); about 27% vs pro forma R1.43 after the 7c dividend | about 12% (Sep 2026) | Narrowed from 40s (Sep 2026) | Deep (not quantified in sources) |
NAV per share growth (latest FY) | -15.3% | — | — | — |
Gearing | Nil (net cash R231m) | — | — | — |
R&D intensity | n/m | n/m | n/m | n/m |



